Japan's day, wrapped and delivered by morning.
Latest Tokyo Brief coverage on Kohjin Bio Co., Ltd., tracking filings, financial news, and market signals from Japan.
TSE:177A
The move: Kohjin Bio adopted an audit-and-supervisory-committee model and split the top representative role between Takahito Nakamura as chairman and Yuichi Nakamura as president, while a same-day disclosure showed Takahito still controlled 53.91% of voting rights.
The move: Kohjin Bio’s shareholders approved an audit and supervisory committee structure, split the top jobs between a chair and president, and signed off on a ¥10 per share dividend worth ¥51.1mn. Separately, Takahito Nakamura remained disclosed as the controlling shareholder with 53.91% of voting rights.